Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 8361237, 9 pages
https://doi.org/10.1155/2017/8361237
Research Article

Serum miRNAs miR-23a, 206, and 499 as Potential Biomarkers for Skeletal Muscle Atrophy

1National Key Laboratory of Human Factors Engineering, China Astronaut Research and Training Center, No. 26 Beiqing Road, Beijing 100094, China
2State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, No. 26 Beiqing Road, Beijing 100094, China

Correspondence should be addressed to Xiaoping Chen; moc.361@9002nehcpx

Received 10 May 2017; Revised 26 June 2017; Accepted 10 July 2017; Published 30 October 2017

Academic Editor: Prescott B. Chase

Copyright © 2017 Fei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Bodine and L. M. Baehr, “Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 307, no. 6, pp. E469–E484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. N. E. Brooks and K. H. Myburgh, “Skeletal muscle wasting with disuse atrophy is multi-dimensional: The response and interaction of myonuclei, satellite cells and signaling pathways,” Frontiers in Physiology, vol. 5, Article ID Article 99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Schiaffino, K. A. Dyar, S. Ciciliot, B. Blaauw, and M. Sandri, “Mechanisms regulating skeletal muscle growth and atrophy,” FEBS Journal, vol. 280, no. 17, pp. 4294–4314, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Dutt, S. Gupta, R. Dabur, E. Injeti, and A. Mittal, “Skeletal muscle atrophy: potential therapeutic agents and their mechanisms of action,” Pharmacological Research, vol. 99, pp. 86–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Koukourikos, A. Tsaloglidou, and L. Kourkouta, “Muscle atrophy in intensive care unit patients,” Acta Informatica Medica, vol. 22, no. 6, pp. 406–410, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. B. Heymsfield, M. Adamek, M. C. Gonzalez, G. Jia, and D. M. Thomas, “Assessing skeletal muscle mass: Historical overview and state of the art,” Journal of Cachexia, Sarcopenia and Muscle, vol. 5, no. 1, pp. 9–18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Scharf and J. Heineke, “Finding good biomarkers for sarcopenia,” Journal of Cachexia, Sarcopenia and Muscle, vol. 3, no. 3, pp. 145–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. S. Patel, M. Z. Molnar, J. A. Tayek et al., “Serum creatinine as a marker of muscle mass in chronic kidney disease: Results of a cross-sectional study and review of literature,” Journal of Cachexia, Sarcopenia and Muscle, vol. 4, no. 1, pp. 19–29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Nedergaard, M. A. Karsdal, S. Sun, and K. Henriksen, “Serological muscle loss biomarkers: An overview of current concepts and future possibilities,” Journal of Cachexia, Sarcopenia and Muscle, vol. 4, no. 1, pp. 1–17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Nedergaard, S. Sun, M. A. Karsdal et al., “Type VI collagen turnover-related peptides-novel serological biomarkers of muscle mass and anabolic response to loading in young men,” Journal of Cachexia, Sarcopenia and Muscle, vol. 4, no. 4, pp. 267–275, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kovanda, T. Režen, and B. Rogelj, “MicroRNA in skeletal muscle development, growth, atrophy, and disease,” Wiley Interdisciplinary Reviews: RNA, vol. 5, no. 4, pp. 509–525, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. X. H. Wang, “MicroRNA in myogenesis and muscle atrophy,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 16, no. 3, pp. 258–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Li, Q.-S. Li, W.-B. Li et al., “miRNA targeted signaling pathway in the early stage of denervated fast and slow muscle atrophy,” Neural Regeneration Research, vol. 11, no. 8, pp. 1293–1303, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. V. de Guire, R. Robitaille, N. Tétreault et al., “Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges,” Clinical Biochemistry, vol. 46, pp. 846–860, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Chakraborty and S. Das, “Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers,” Tumor Biology, vol. 37, no. 5, pp. 5705–5714, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Mirra, G. A. Raciti, C. Nigro et al., “Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes,” Epigenomics, vol. 7, no. 4, pp. 653–667, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Li, Y. Li, L. Zhao et al., “Circulating muscle-specific miRNAs in Duchenne muscular dystrophy patients,” Molecular Therapy—Nucleic Acids, vol. 3, no. 7, p. e177, 2014. View at Publisher · View at Google Scholar
  18. A. Koutsoulidou, T. C. Kyriakides, G. K. Papadimas et al., “Elevated muscle-specific miRNAs in serum of myotonic dystrophy patients relate to muscle disease progress,” PLoS ONE, vol. 10, no. 4, Article ID e0125341, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Cloutier, A. Marrero, C. O’Connell, and P. Morin, “MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis,” Journal of Molecular Neuroscience, vol. 56, no. 1, pp. 102–112, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Tasca, V. Pegoraro, A. Merico, and C. Angelini, “Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS,” Clinical Neuropathology, vol. 35, no. 1, pp. 22–30, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Nie, Z.-L. Deng, J. Liu, and D.-Z. Wang, “Noncoding RNAs, emerging regulators of skeletal muscle development and diseases,” BioMed Research International, vol. 2015, Article ID 676575, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Wang, F. Wang, P. Zhang et al., “PGC-1α over-expression suppresses the skeletal muscle atrophy and myofiber-type composition during hindlimb unloading,” Bioscience, Biotechnology and Biochemistry, vol. 81, no. 3, pp. 500–513, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Naito, S. K. Powers, H. A. Demirel, T. Sugiura, S. L. Dodd, and J. Aoki, “Heat stress attenuates skeletal muscle atrophy in hindlimb-unweighted rats,” Journal of Applied Physiology, vol. 88, no. 1, pp. 359–363, 2000. View at Google Scholar · View at Scopus
  24. K. Lee, Y. S. Lee, M. Lee, M. Yamashita, and I. Choi, “Mechanics and fatigability of the rat soleus muscle during early reloading,” Yonsei Medical Journal, vol. 45, no. 4, pp. 690–702, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. E. R. Morey-Holton and R. K. Globus, “Hindlimb unloading rodent model: technical aspects,” Journal of Applied Physiology, vol. 92, no. 4, pp. 1367–1377, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Wang, P. Zhang, H. Liu, M. Fan, and X. Chen, “Proteomic analysis of mouse soleus muscles affected by hindlimb unloading and reloading,” Muscle and Nerve, vol. 52, no. 5, pp. 803–811, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Rommel, S. C. Bodine, B. A. Clarke et al., “Mediation of IGF-1-induced skeletal myotube hypertrophy by Pl(3)K/Alt/mTOR and Pl(3)K/Akt/GSK3 pathways,” Nature Cell Biology, vol. 3, no. 11, pp. 1009–1013, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Xu, C. Tan, P. Li et al., “Changes of Cytokines during a Spaceflight Analog - a 45-Day Head-Down Bed Rest,” PLoS ONE, vol. 8, no. 10, Article ID e77401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Ye, S. Mathur, M. Liu et al., “Overexpression of insulin-like growth factor-1 attenuates skeletal muscle damage and accelerates muscle regeneration and functional recovery after disuse,” Experimental Physiology, vol. 98, no. 5, pp. 1038–1052, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Jayaraman, M. Liu, F. Ye, G. A. Walter, and K. Vandenborne, “Regenerative responses in slow- and fast-twitch muscles following moderate contusion spinal cord injury and locomotor training,” European Journal of Applied Physiology, vol. 113, no. 1, pp. 191–200, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Morey-Holton, R. K. Globus, A. Kaplansky, and G. Durnova, “The hindlimb unloading rat model: literature overview, technique update and comparison with space flight data,” Advances in Space Biology and Medicine, vol. 10, pp. 7–40, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. S. F. Cui, C. Wang, X. Yin et al., “Similar responses of circulating microRNAs to acute high-intensity interval exercise and vigorous-intensity continuous exercise,” Frontiers in Physiology, vol. 7, article no. 102, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. J. F. Chen, E. M. Mandel, J. M. Thomson et al., “The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation,” Nature Genetics, vol. 38, no. 2, pp. 228–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Wada, Y. Kato, M. Okutsu et al., “Translational suppression of atrophic regulators by MicroRNA-23a integrates resistance to skeletal muscle atrophy,” The Journal of Biological Chemistry, vol. 286, no. 44, pp. 38456–38465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. B. Hudson, M. E. Woodworth-Hobbs, B. Zheng et al., “miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export,” The American Journal of Physiology—Cell Physiology, vol. 306, no. 6, pp. C551–C558, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. V. J. Caiozzo, M. J. Baker, and K. M. Baldwin, “Novel transitions in MHC isoforms: Separate and combined effects of thyroid hormone and mechanical unloading,” Journal of Applied Physiology, vol. 85, no. 6, pp. 2237–2248, 1998. View at Google Scholar · View at Scopus
  37. R. H. Fitts, D. R. Riley, and J. J. Widrick, “Physiology of a microgravity environment invited review: Microgravity and skeletal muscle,” Journal of Applied Physiology, vol. 89, no. 2, pp. 823–839, 2000. View at Google Scholar · View at Scopus
  38. C. F. Sams, B. E. Crucian, R. P. Stowe et al., “Immune status, latent viral reactivation, and stress during long-duration head-down bed rest,” Aviation Space and Environmental Medicine, vol. 80, no. 5, pp. A37–A44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Kamiya, S. Iwase, H. Kitazawa, and T. Mano, “Muscle sympathetic nerve activity (MSNA) after 120 days of 6 degrees head-down bed rest (HDBR),” Environmental Medicine, vol. 43, no. 2, pp. 150–152, 1999. View at Google Scholar · View at Scopus
  40. F. Louisy, P. Schroiff, and A. Güell, “Changes in leg vein filling and emptying characteristics and leg volumes during long-term head-down bed rest,” Journal of Applied Physiology, vol. 82, no. 6, pp. 1726–1733, 1997. View at Google Scholar · View at Scopus